Abstract

Research Article

Prevalence of West Nile Virus among Sudanese Participants in Gezira State

Sara Elsadig Elagib Eltahir, Nasir Adam Ibrahim and Omer Hassan Mohamed

Published: 22 September, 2025 | Volume 9 - Issue 1 | Pages: 005-008

West Nile virus (WNV), a mosquito-borne pathogen belonging to the Flavivirus genus (family Flaviviridae), is primarily responsible for West Nile fever. In rare cases (< 1% of infections), it can lead to West Nile neuroinvasive disease (WNND), which carries an approximate fatality rate of 10%. This cross-sectional study aimed to assess WNV exposure among residents of Gezira State, Sudan, from 2019 to 2022. A total of 400 participants were included, with 5 mL of blood collected from each—2 mL in an EDTA tube and 3 mL in a plain container. Plasma and serum were separated via centrifugation, and WNV-specific IgG and IgM antibodies were detected using ELISA. The results revealed that 62.25% (249 cases) tested positive for WNV-IgG antibodies, while 37.75% (151 cases) were negative. None of the samples showed detectable WNV-IgM antibodies. Statistical analysis indicated no significant association between WNV-IgG seropositivity and age or gender (p = 0.060 and 
p = 0.117, respectively). However, significant correlations were observed with marital status and education level (p < 0.05). The study highlights the need for ongoing surveillance of WNV and other vector-borne diseases in the region to identify active West Nile Virus infections. Public health efforts should prioritize mosquito control measures, community education, and awareness campaigns about WNV symptoms and prevention.

Read Full Article HTML DOI: 10.29328/journal.apcr.1001045 Cite this Article Read Full Article PDF

Keywords:

West nile virus; Flavivirus; Mosquito-borne; Seroprevalence; Vector-borne diseases

References

  1. Petersen LR, Brault AC, Nasci RS. West Nile virus: Review of the literature. JAMA. 2013;310(3):308–15. Available from: https://doi.org/10.1001/jama.2013.8042
  2. Centers for Disease Control and Prevention (CDC). General questions about West Nile virus. 2017. Archived from the original on 26 Oct 2017. Retrieved 26 Oct 2017. Available from: https://www.cdc.gov/westnile/faq/genQuestions.html
  3. World Health Organization. West Nile virus. 2011. Archived from the original on 18 Oct 2017. Retrieved 28 Oct 2017. Available from: https://www.who.int/news-room/fact-sheets/detail/west-nile-virus
  4. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis. 2002;2(9):519–29. Available from: https://doi.org/10.1016/s1473-3099(02)00368-7
  5. Solomon T, Cardosa MJ. Emerging arboviral encephalitis. BMJ. 2000;321(7275):1484–5. Available from: https://doi.org/10.1136/bmj.321.7275.1484
  6. Kavle J, Legros D. Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002 - West Nile virus IgG antibodies among blood donors in Sudan: a cross-sectional study. 2004.
  7. Amin YES, Ahmed-Abakur EH. West Nile virus IgG antibodies among blood donors in Sudan: a cross-sectional study. New Microbes New Infect. 2020;48:101062. PMID: 36568644; PMCID: PMC9772833. Available from: https://doi.org/10.1016/j.nmni.2022.101062
  8. Murgue B, Zeller H, Deubel V. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol. 2002;267:195–221. Available from: https://doi.org/10.1007/978-3-642-59403-8_10
  9. Hamer DH, Angelo K, Caumes E, van Genderen PJJ, Florescu SA, Popescu CP, et al. Fatal Yellow Fever in Travelers to Brazil, 2018. MMWR Morb Mortal Wkly Rep. 2018;67(11):340–1. Available from: https://doi.org/10.15585/mmwr.mm6711e1
  10. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA. 2003;290(4):524–8. Available from: https://doi.org/10.1001/jama.290.4.524

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?